X0206 3 2022-06-08 0 0001681087 AVROBIO, Inc. AVRO 0001932510 Golipour Azadeh C/O AVROBIO, INC. ONE KENDALL SQUARE, BLD. 300 - SUITE 201 CAMBRIDGE MA 02139 1 Chief Technology Officer Common Stock 36344 D Stock Option (Right to Buy) 1.20 2026-10-24 Common Stock 353 D Stock Option (Right to Buy) .91 2027-06-12 Common Stock 736 D Stock Option (Right to Buy) 5.00 2028-03-15 Common Stock 5908 D Stock Option (Right to Buy) 16.98 2029-02-24 Common Stock 20000 D Stock Option (Right to Buy) 20.98 2030-03-01 Common Stock 31500 D Stock Option (Right to Buy) 14.57 2031-01-03 Common Stock 25000 D Stock Option (Right to Buy) 16.02 2031-02-03 Common Stock 46000 D Stock Option (Right to Buy) 1.84 2032-02-01 Common Stock 100000 D Stock Option (Right to Buy) 1.84 2032-02-01 Common Stock 130000 D Consists of 36,344 RSUs granted on June 10, 2021. 50% of the shares vest on the second anniversary of the grant date and the remaining 50% vest on the third anniversary of the grant date. Fully vested. 25% of the shares vested on February 25, 2020, and the remaining 75% vest in equal monthly installments thereafter over a three-year period. 25% of the shares vested on March 2, 2021, and the remaining 75% vest in equal monthly installments thereafter over a three-year period. 25% of the shares vested on January 4, 2022, and the remaining 75% vest in equal monthly installments thereafter over a three-year period. 25% of the shares vested on February 4, 2022, and the remaining 75% vest in equal monthly installments thereafter over a three-year period. 25% of the shares vest on February 2, 2023, and the remaining 75% vest in equal monthly installments thereafter over a three-year period. Exhibit 24 - Power of Attorney /s/ Christopher Gerry, Attorney in Fact for Azadeh Golipour 2022-06-17